EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Current status of nucleic acid therapy and its new progress in cancer treatment

Wenting Lou, Leqi Zhang, Jianwei Wang

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.113157 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Wenting Lou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medici…. Hauptthemen laut MEDLINE: Neoplasms, Nucleic Acids. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleic acid is an essential biopolymer in all living cells, performing the functions of storing and transmitting genetic information and synthesizing protein. In recent decades, with the progress of science and biotechnology and the continuous exploration of the functions performed by nucleic acid, more and more studies have confirmed that nucleic acid therapy for living organisms has great medical therapeutic potential. Nucleic acid drugs began to become independent therapeutic agents. As a new therapeutic method, nucleic acid therapy plays an important role in the treatment of genetic diseases, viral infections and cancers. There are currently 19 nucleic acid drugs approved by the Food and Drug Administration (FDA). In the following review, we start from principles and advantages of nucleic acid therapy, and briefly describe development history of nucleic acid drugs. And then we give examples of various RNA therapeutic drugs, including antisense oligonucleotides (ASO), mRNA vaccines, small interfering RNA (siRNA) and microRNA (miRNA), aptamers, and small activating RNA (saRNA). In addition, we also focused on the current status of nucleic acid drugs used in cancer therapy and the breakthrough in recent years. Clinical trials of nucleic acid drugs for cancer treatment are under way, conventional radiotherapy and chemotherapy combined with the immunotherapies such as checkpoint inhibitors and nucleic acid drugs may be the main prospects for successful cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNucleic AcidsHumansAnimalsGenetic TherapyOligonucleotides, AntisenseRNA, Small InterferingImmunotherapy

Stichwörter der Autor:innen

Antisense oligonucleotidesCancer treatmentNucleic acid therapymRNA vaccinesmiRNAsiRNA

Substanzen

Nucleic AcidsOligonucleotides, AntisenseRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China.
  • Department of Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, International Institutes of Medicine, Zhejiang University, Yiwu 322000, China; Department of Colorectal…

Zitieren

APA

Lou, W., Zhang, L., & Wang, J. (2024). Current status of nucleic acid therapy and its new progress in cancer treatment. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.113157

Vancouver

Lou W, Zhang L, Wang J. Current status of nucleic acid therapy and its new progress in cancer treatment. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.113157

BibTeX
@article{Lou2024,
  author = {Lou, Wenting and Zhang, Leqi and Wang, Jianwei},
  title = {Current status of nucleic acid therapy and its new progress in cancer treatment},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.113157}
}
Kostenlos starten →